Thyroid nodule historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 34: Line 34:
* In 1947, Cope, Rawson, and McArthur were the first who described the usage of [[radioactive iodine]] to demonstrate a "hot" thyroid nodule.
* In 1947, Cope, Rawson, and McArthur were the first who described the usage of [[radioactive iodine]] to demonstrate a "hot" thyroid nodule.
* In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine [[Needle biopsy|needle thyroid biopsy]] as a diagnostic method for thyroid nodules.
* In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine [[Needle biopsy|needle thyroid biopsy]] as a diagnostic method for thyroid nodules.
* In 1949, R. G. Hoskins was the first who described negative feedback of [[thyroid gland]] on pituitary, a mechanism that he called "servo (feedback) mechanism".
* In 1949, R. G. Hoskins was the first who described negative feedback of [[thyroid gland]] on [[pituitary]], a mechanism that he called "servo (feedback) mechanism".
* In 1950, J. B. Stanbury was the first who described the genetic abnormality association with [[Thyroid hormones|thyroid hormone]] synthesis.
* In 1950, J. B. Stanbury was the first who described the genetic abnormality association with [[Thyroid hormones|thyroid hormone]] synthesis.
* In 1959, J. B. Hazard, W. A. Hawk, and G. Crile were the first eho described [[medullary thyroid cancer]] as a distinct entity.
* In 1959, J. B. Hazard, W. A. Hawk, and G. Crile were the first who described [[medullary thyroid cancer]] as a distinct entity.
* In 1965, S. Berson and R. Yalow were the first who described [[radioimmunoassay]] procedure.
* In 1965, S. Berson and R. Yalow were the first who described [[radioimmunoassay]] procedure.
* In 1966, R. F. Rohner, J. T. Prior and J. H. Sipple were the first who described [[multiple endocrine neoplasia type 2]] and reported some cases.
* In 1966, R. F. Rohner, J. T. Prior and J. H. Sipple were the first who described [[multiple endocrine neoplasia type 2]] and reported some cases.
Line 51: Line 51:
* In 340, Ko-Hung, a chinese alchemist recommended seaweed for treatment of [[goiter]] among people living in mountains.
* In 340, Ko-Hung, a chinese alchemist recommended seaweed for treatment of [[goiter]] among people living in mountains.
* In 650, Sun Ssu-Mo, another chinese physician, used dried, powdered mollusca shells and chopped [[thyroid gland]] for the treatment of [[Goiter|goiter.]]
* In 650, Sun Ssu-Mo, another chinese physician, used dried, powdered mollusca shells and chopped [[thyroid gland]] for the treatment of [[Goiter|goiter.]]
* In 1200, Arnaldus de Villanova reported that marine sponges could be used to treat [[goiter]]<nowiki/>s.
* In 1200, Arnaldus de Villanova reported that marine sponges could be used to treat [[Goiters|goiter<nowiki/>s]].
* In 1475, Wang Hei, a chinese physician recommended treat of [[goiter]] with minced [[Thyroid gland|thyroid gland.]]
* In 1475, Wang Hei, a chinese physician recommended treat of [[goiter]] with minced [[Thyroid gland|thyroid gland.]]
* In 1857, Maurice Schiff was the first to perform a successful total [[Thyroidectomy|thyroidectomies]] in animals.
* In 1857, Maurice Schiff was the first to perform a successful total [[Thyroidectomy|thyroidectomies]] in animals.
Line 64: Line 64:


== Landmark events ==
== Landmark events ==
* In 1831, Iodine prophylaxis proposed as a goverment-administered [[public health]] program, for [[goiter]] prevention.
* In 1831, Iodine [[prophylaxis]] proposed as a goverment-administered [[public health]] program, for [[goiter]] prevention.
* In 1998, United States scientists were the first that approved clinical usage of recombinant human [[TSH]].
* In 1998, United States scientists were the first that approved clinical usage of recombinant human [[TSH]].



Revision as of 16:46, 19 October 2017

Thyroid nodule Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thyroid nodule from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thyroid nodule historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thyroid nodule historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thyroid nodule historical perspective

CDC on Thyroid nodule historical perspective

Thyroid nodule historical perspective in the news

Blogs on Thyroid nodule historical perspective

Directions to Hospitals Treating Thyroid nodule

Risk calculators and risk factors for Thyroid nodule historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

In 1500, Leonardo da Vinci was the first who recognized and drew the thyroid gland. In 1834, Robert Graves was the first who described described a syndrome of palpitation, goiter, and exophthalmos. In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals. In 1895, Adolf Magnus Levy was the first to describe the influence of the thyroid gland and thyroid hormones on the basal metabolic rate. In 1947, Cope, Rawson, and McArthur were the first who described the usage of radioactive iodine to demonstrate a "hot" thyroid nodule. In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine needle thyroid biopsy as a diagnostic method for thyroid nodules.[1]

Historical perspective


Treatment history

  • In 2700 BC, seaweed was used for the treatment of goiter.
  • In 340, Ko-Hung, a chinese alchemist recommended seaweed for treatment of goiter among people living in mountains.
  • In 650, Sun Ssu-Mo, another chinese physician, used dried, powdered mollusca shells and chopped thyroid gland for the treatment of goiter.
  • In 1200, Arnaldus de Villanova reported that marine sponges could be used to treat goiters.
  • In 1475, Wang Hei, a chinese physician recommended treat of goiter with minced thyroid gland.
  • In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals.
  • In 1891, G. R. Murray was the first who described the effect of thyroid hormone extract in treating myxedema.
  • In 1905, Dr. Robert Abbe was the first who treated the Graves disease by implanting radium into the patients goiter.
  • In 1914, E. C. Kendall was the first who isolated thyroxine.
  • In 1917, M. Seymour in Boston was the first who described the usage of X ray for treating Graves disease.
  • In 1924, H. S. Plummer at the Mayo clinic was the first who described the pre-operative usage of iodine for Graves disease treatment.
  • In 1928, Harington and Barger were the first who described the chemical structure of thyroxine and synthesize it.
  • In 1946, A. Astwood was the first who used thiourea and thiouracil for medical treatment of Graves disease.
  • In 1949, Jones, Kornfeld, McLaughlin, and Anderson were the first who synthesize methimazole.

Landmark events

  • In 1831, Iodine prophylaxis proposed as a goverment-administered public health program, for goiter prevention.
  • In 1998, United States scientists were the first that approved clinical usage of recombinant human TSH.

References

  1. "Thyroid History Timeline | American Thyroid Association".

Template:WH Template:WS